These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7371699)

  • 61. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog.
    Gustafson C; Ahlgren I; Aronsen KF; Rosberg B
    Br J Anaesth; 1981 Jun; 53(6):585-90. PubMed ID: 7248122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol.
    Andersson O; Berglund G; Hansson L
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):757-61. PubMed ID: 1032990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
    Lund-Johansen P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):107S-111S. PubMed ID: 583322
    [No Abstract]   [Full Text] [Related]  

  • 66. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H; Kanto J; Pakkanen A; Wendelin H
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.
    Kaufman L
    Br J Clin Pharmacol; 1979; 8(Suppl 2):229S-232S. PubMed ID: 526406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulatory effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Littlewood DG; Macrae WR; Arthur GR; Drummond GB
    Anaesthesia; 1978 Feb; 33(2):145-56. PubMed ID: 637271
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravenous labetalol in severe hypertension.
    Dal Palu C; Pessina AC; Semplicini A; Hlede M; Morandin F; Palatini P; Sperti G; Rossi GP
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):97S-99S. PubMed ID: 7093106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Hemodynamic effects of labetalol on the humeral artery of the hypertensive patient. A double-blind study versus placebo].
    Pithois-Merli I; Cournot AX; Georges DR; Pappo M; Safar ME
    Ann Cardiol Angeiol (Paris); 1987; 36(7):371-4. PubMed ID: 3662385
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

  • 76. Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol.
    Roy L; Mehta J; Mehta P
    Am J Cardiol; 1983 Feb; 51(3):464-7. PubMed ID: 6823861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 78. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prolactin stimulation by intravenous labetalol is mediated inside the central nervous system.
    Barbieri C; Larovere MT; Mariotti G; Ferrari C; Caldara R
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):615-9. PubMed ID: 7105431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
    van der Veur E; ten Berge BS; Wouda AA; Wesseling H
    Eur J Clin Pharmacol; 1985; 28(2):131-4. PubMed ID: 3987794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.